KentCardio

11/12/2025

Recent research suggests that a fixed-dose combination 'polypill', combining blood pressure and cholesterol medications, can lower the risk of heart attack and stroke. In large trials, polypills reduced cardiovascular risk by around 21–31% compared with placebo.

While this strategy offers promise in simplifying prevention and improving adherence, there’s ongoing debate over whether a broad approach is appropriate compared with individualised risk assessment.

In his latest article, Dr Konrad Grosser explores the limitations of the polypill in isolation and highlights how functional testing, systems biology, and targeted intervention can reveal hidden risk factors far earlier than traditional models alone.

Learn more in the latest news article > https://kentcardio.com/latest-news/individualised-care-vs-the-polypill-debate/

11/12/2025

Intermittent fasting is usually associated with weight management, but emerging research suggests that it could also benefit brain health and cognitive function. Studies show that fasting patterns may improve insulin sensitivity, support metabolic shifts that reduce inflammation and oxidative stress, and enhance memory and executive function compared with standard healthy diets. In some cases, intermittent fasting has been linked with improved markers of brain aging and better metabolic health in older adults.

In our latest article, Dr Konrad Grosser explores how intermittent fasting might influence biological aging and cognitive performance. Take a look here > https://kentcardio.com/latest-news/intermittent-fasting-and-the-cognitive-benefits-for-your-brain/

23/10/2025

Diagnoses of type 2 diabetes in people under 40 have surged by 40% in recent years.

In the latest blog, we look at how insulin resistance and metabolic dysfunction often begin years before diagnosis occurs. We explore how advanced testing, such as insulin resistance assessments, mitochondrial function, and biological age screening, can identify risk early and pave the way to real prevention.

Discover why early intervention matters and how a targeted, functional-medicine approach can help >

If you're concerned about blood sugar, insulin, or weight gain, book a consultation to explore your metabolic health and for treatments.

06/10/2025

In his new article, Dr Konrad Grosser explores a promising breakthrough treatment for adrenal-based hypertension, a subtype of high blood pressure rooted in hormonal and adrenal dysfunction, often overlooked in standard care.

By digging deeper into endocrine, metabolic, and hormonal systems, functional screening can reveal the hidden causes behind seemingly 'ordinary' hypertension. From there, a targeted, systems biology-based plan can address root drivers rather than just masking symptoms.

Read more: https://kentcardio.com/latest-news/a-breakthrough-treatment-for-adrenal-based-hypertension/

16/09/2025

With rising global temperatures, heatwaves aren’t just uncomfortable – they’re becoming a serious health risk, especially for older adults.

In our latest article, we explore how prolonged heat exposure impacts heart, metabolic, and immune systems – and why early detection through advanced screening is more important than ever. We share practical steps you can take now: optimising hydration, protecting sleep, checking blood pressure and heart health, supporting detox pathways, and using functional tests to uncover hidden risk.

Learn more here - https://kentcardio.com/latest-news/rising-heatwaves-and-impact-on-aging-populations/

03/09/2025

A recent groundbreaking study from the University of Surrey has uncovered specific genetic variants that elevate the risk of both type 2 diabetes and certain cancers – including breast, colorectal, and pancreatic cancer.

Through advanced functional screening, including TruAge and TruIntelli testing, combined with Dr Konrad Grosser’s systems biology approach, you can identify AND influence your true risk profile.

Discover practical strategies for early intervention:

• Targeted metabolic and hormone testing
• Nutritional optimisation and lifestyle support
• Personalised plans for cancer prevention and metabolic health

Read the full article here - https://kentcardio.com/latest-news/genetic-link-between-type-2-diabetes-and-cancer/

14/08/2025

Weight-Loss Medications and Diabetes.

GLP-1 drugs like Ozempic and Mounjaro can be a powerful starting point for improving blood sugar control, supporting weight loss, and reducing health risks.

But lasting success in managing diabetes and metabolic health needs more than medication. Dr Konrad Grosser uses a targeted, medically supervised approach – combining early intervention, metabolic reset, and sustainable lifestyle changes to optimise long-term health.

Read the full blog here - https://kentcardio.com/latest-news/can-weight-loss-medications-help-with-diabetes/

07/08/2025

🧠 Are standard health checks giving you the full picture?

Many routine screenings only look at surface-level markers like cholesterol or blood pressure. While these can flag some risks, they often miss the early signs of deeper issues – like inflammation, hormonal imbalance, poor detox function, or nutrient depletion –that can silently increase your risk of heart disease, dementia, diabetes, and cancer.

At KentCardio, Dr Konrad Grosser takes a systems biology approach, using advanced diagnostics and functional testing to uncover what's really driving your health.

Learn more in the latest article here -

Standard health screenings often miss the early warning signs of disease. Stay ahead of the curve with functional testing at Kent Cardio.

09/07/2025

Many believe memory loss and cognitive decline are an inevitable part of aging. But the truth is, changes in brain metabolism, inflammation, and detox pathways often begin 10–20 years before symptoms appear.

In this news article, Dr Konrad Grosser explains why early, proactive screening for brain health is crucial, and how advanced testing and a systems biology approach can help you identify and address risk factors now, rather than waiting until it’s too late.

Take a look at the new blog here > https://kentcardio.com/latest-news/cognitive-decline-starts-decades-before-symptoms-can-you-afford-to-wait/

01/07/2025

Is your metabolism putting your long-term health at risk?

Insulin resistance and central obesity don’t just increase your risk of diabetes – they can quietly drive inflammation, accelerate cardiovascular disease, raise your cancer risk, and even impact brain health.

In his latest article, Dr Konrad Grosser explains why these hidden metabolic imbalances often go undetected until serious health issues arise, and how advanced, functional testing can identify problems early so you can take action before symptoms develop.

Discover how a personalised, systems biology approach can help you break the metabolic trap and support long-term health.

Read the article here - https://kentcardio.com/latest-news/how-diabetes-and-obesity-quietly-accelerate-disease/